Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00907127 · ClinicalTrials.gov registry record · Phase 1

Cardiac Autonomic Neuropathy in Patients With Metabolic Syndrome

A Phase 1 study of Metabolic Syndrome, sponsored by University of Michigan.

Completed
Registry status
Phase 1
Development phase
50
Enrollment target
1
Study location

NCT00907127 is a Phase 1 study of Metabolic Syndrome that has completed, run by University of Michigan. The registered enrollment target is 50 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00907127, a Phase 1 study of Metabolic Syndrome, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 1
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The study will test whether damage of the heart nerves appears in patients before they develop diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise and Diet (Metabolic Fitness Program)

Study Locations (1)

Michigan

  • The University of Michigan Health System - Ann Arbor

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2007-01
Est. Completion 2011-12
Phase Phase 1

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT00907127

The ClinicalTrials.gov registry entry for NCT00907127 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Exercise and Diet (Metabolic Fitness Program) is the first listed.

NCT00907127 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT00907127 about?

NCT00907127 is a clinical study titled "Cardiac Autonomic Neuropathy in Patients With Metabolic Syndrome". The study will test whether damage of the heart nerves appears in patients before they develop diabetes.

What is the current status of trial NCT00907127?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2007-01. Estimated completion is 2011-12.

What conditions does trial NCT00907127 study?

This clinical trial studies the following conditions: Metabolic Syndrome.

What interventions are being tested in trial NCT00907127?

The interventions under investigation include: Exercise and Diet (Metabolic Fitness Program) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00907127?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00907127 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.